GCA independently raises risk for VTE

mdedge.com January 10, 2017

The risk of venous thromboembolism (VTE) increases markedly shortly before the diagnosis of giant cell arteritis (GCA) regardless of glucocorticoid exposure, peaks at the time of diagnosis, and then progressively declines, according to a matched cohort review involving more than 6,000 arteritis patients.

inflammation risk study thromboembolism VTE

AKI Risk Factors in ICU Patients Using Colistin

AKI Risk Factors in ICU Patients Using Colistin

VTE in Critically Ill Adult Patients with Hematologic Malignancy

VTE in Critically Ill Adult Patients with Hematologic Malignancy

Clinical Outcomes in Critically Ill COVID-19 Unvaccinated Patients Admitted to the ICU

Clinical Outcomes in Critically Ill COVID-19 Unvaccinated Patients Admitted to the ICU

Haloperidol vs. Placebo in ICU Patients with Delirium

Haloperidol vs. Placebo in ICU Patients with Delirium

Quick Reference to Critical Care

Avoiding Common Errors in the Emergency Department

When Brains Collide: What Every Athlete and Parent Should Know About the Prevention and Treatment of Concussions and Head Injuries

Hot Lights, Cold Steel: Life, Death and Sleepless Nights in a Surgeon’s First Years

Priorities in Critical Care Nursing

Trauma

Acute Lung Injury: Epidemiology, Health Effects and Therapeutic Treatment Strategies

Sepsis Management: PIRO and MODS

Extracorporeal Life Support for Adults

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

Critical Care: A New Nurse Faces Death, Life, and Everything in Between